

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vocalization behavior (GO:0071625) | 5.82180559 |
| 2 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.76588452 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.72576110 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.65153010 |
| 5 | locomotory exploration behavior (GO:0035641) | 5.61739586 |
| 6 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.33247300 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 5.26054413 |
| 8 | synaptic vesicle maturation (GO:0016188) | 5.22810717 |
| 9 | neuron cell-cell adhesion (GO:0007158) | 5.18121788 |
| 10 | protein localization to synapse (GO:0035418) | 5.15359434 |
| 11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.14743552 |
| 12 | glutamate secretion (GO:0014047) | 4.92406001 |
| 13 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.91927602 |
| 14 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.89383392 |
| 15 | exploration behavior (GO:0035640) | 4.80030596 |
| 16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.77589541 |
| 17 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.72390281 |
| 18 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.60272444 |
| 19 | regulation of synapse structural plasticity (GO:0051823) | 4.57561806 |
| 20 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.39735730 |
| 21 | positive regulation of synapse maturation (GO:0090129) | 4.37156088 |
| 22 | regulation of synaptic vesicle transport (GO:1902803) | 4.31812627 |
| 23 | layer formation in cerebral cortex (GO:0021819) | 4.30535194 |
| 24 | postsynaptic membrane organization (GO:0001941) | 4.30084666 |
| 25 | glutamate receptor signaling pathway (GO:0007215) | 4.22997323 |
| 26 | synaptic transmission, glutamatergic (GO:0035249) | 4.19757413 |
| 27 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.06853950 |
| 28 | neuron-neuron synaptic transmission (GO:0007270) | 4.05708013 |
| 29 | neurotransmitter secretion (GO:0007269) | 4.04827904 |
| 30 | presynaptic membrane assembly (GO:0097105) | 4.04451599 |
| 31 | macrophage activation involved in immune response (GO:0002281) | 4.04161461 |
| 32 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.02100020 |
| 33 | neuron recognition (GO:0008038) | 3.97515959 |
| 34 | negative regulation of interleukin-12 production (GO:0032695) | 3.96100000 |
| 35 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.89488739 |
| 36 | response to peptidoglycan (GO:0032494) | 3.88649952 |
| 37 | proline transport (GO:0015824) | 3.80344630 |
| 38 | dendritic spine morphogenesis (GO:0060997) | 3.75257925 |
| 39 | positive regulation of membrane potential (GO:0045838) | 3.73914312 |
| 40 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.71659025 |
| 41 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.69408538 |
| 42 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.69408538 |
| 43 | modulation by symbiont of host immune response (GO:0052553) | 3.69408538 |
| 44 | positive regulation by symbiont of host defense response (GO:0052509) | 3.69408538 |
| 45 | modulation by symbiont of host defense response (GO:0052031) | 3.69408538 |
| 46 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.69408538 |
| 47 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.67770297 |
| 48 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.65149268 |
| 49 | regulation of postsynaptic membrane potential (GO:0060078) | 3.64753523 |
| 50 | long-term memory (GO:0007616) | 3.63962470 |
| 51 | presynaptic membrane organization (GO:0097090) | 3.63330030 |
| 52 | response to histamine (GO:0034776) | 3.61694090 |
| 53 | gamma-aminobutyric acid transport (GO:0015812) | 3.61273231 |
| 54 | long-term synaptic potentiation (GO:0060291) | 3.61178495 |
| 55 | axonal fasciculation (GO:0007413) | 3.60433272 |
| 56 | synaptic vesicle endocytosis (GO:0048488) | 3.60026679 |
| 57 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.59978899 |
| 58 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.57449708 |
| 59 | neutrophil activation involved in immune response (GO:0002283) | 3.57384875 |
| 60 | regulation of synaptic plasticity (GO:0048167) | 3.57272891 |
| 61 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.56669836 |
| 62 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.53641887 |
| 63 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.52056475 |
| 64 | regulation of synapse maturation (GO:0090128) | 3.49679097 |
| 65 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.48719743 |
| 66 | cerebellar granule cell differentiation (GO:0021707) | 3.47529377 |
| 67 | detection of molecule of bacterial origin (GO:0032490) | 3.46696635 |
| 68 | dendrite morphogenesis (GO:0048813) | 3.44705227 |
| 69 | auditory behavior (GO:0031223) | 3.44523135 |
| 70 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.44456168 |
| 71 | activation of protein kinase A activity (GO:0034199) | 3.42160927 |
| 72 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.40484765 |
| 73 | neuronal action potential propagation (GO:0019227) | 3.37094948 |
| 74 | positive regulation of type 2 immune response (GO:0002830) | 3.32408924 |
| 75 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.32056470 |
| 76 | regulation of vesicle fusion (GO:0031338) | 3.30943307 |
| 77 | behavioral defense response (GO:0002209) | 3.30742273 |
| 78 | behavioral fear response (GO:0001662) | 3.30742273 |
| 79 | regulation of neurotransmitter secretion (GO:0046928) | 3.29705048 |
| 80 | microglial cell activation (GO:0001774) | 3.28987496 |
| 81 | positive regulation of neurotransmitter transport (GO:0051590) | 3.26216748 |
| 82 | regulation of dendritic spine development (GO:0060998) | 3.24967991 |
| 83 | nucleobase catabolic process (GO:0046113) | 3.21153069 |
| 84 | response to auditory stimulus (GO:0010996) | 3.18504917 |
| 85 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.17300744 |
| 86 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.17271513 |
| 87 | clathrin coat assembly (GO:0048268) | 3.15177441 |
| 88 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.13799803 |
| 89 | synapse assembly (GO:0007416) | 3.13245638 |
| 90 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.13001947 |
| 91 | neurotransmitter transport (GO:0006836) | 3.11897036 |
| 92 | detection of other organism (GO:0098543) | 3.11606803 |
| 93 | learning (GO:0007612) | 3.10261869 |
| 94 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.09895885 |
| 95 | regulation of female receptivity (GO:0045924) | 3.08300420 |
| 96 | macrophage activation (GO:0042116) | 3.07868368 |
| 97 | fear response (GO:0042596) | 3.04104934 |
| 98 | immunoglobulin mediated immune response (GO:0016064) | 3.04057697 |
| 99 | granulocyte activation (GO:0036230) | 3.03892490 |
| 100 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.03389670 |
| 101 | germinal center formation (GO:0002467) | 3.03340734 |
| 102 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.02943218 |
| 103 | vesicle transport along microtubule (GO:0047496) | 3.02408142 |
| 104 | positive regulation of synaptic transmission (GO:0050806) | 3.01619717 |
| 105 | neutrophil activation (GO:0042119) | 3.01615811 |
| 106 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.00881835 |
| 107 | regulation of glutamate secretion (GO:0014048) | 3.00761269 |
| 108 | T-helper 1 type immune response (GO:0042088) | 3.00521820 |
| 109 | neuromuscular process controlling balance (GO:0050885) | 2.97763652 |
| 110 | dopamine receptor signaling pathway (GO:0007212) | 2.97308059 |
| 111 | transmission of nerve impulse (GO:0019226) | 2.96853960 |
| 112 | startle response (GO:0001964) | 2.96742184 |
| 113 | membrane depolarization (GO:0051899) | 2.96564970 |
| 114 | mechanosensory behavior (GO:0007638) | 2.95750390 |
| 115 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.94376969 |
| 116 | regulation of neurotransmitter transport (GO:0051588) | 2.94261337 |
| 117 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.93395806 |
| 118 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.92317287 |
| 119 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.92271608 |
| 120 | negative regulation of cell killing (GO:0031342) | 2.92271608 |
| 121 | regulation of synaptic transmission (GO:0050804) | 2.91121988 |
| 122 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.89611311 |
| 123 | intraspecies interaction between organisms (GO:0051703) | 2.88569080 |
| 124 | social behavior (GO:0035176) | 2.88569080 |
| 125 | regulation of neurotransmitter levels (GO:0001505) | 2.87951066 |
| 126 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.87475013 |
| 127 | regulation of type 2 immune response (GO:0002828) | 2.87250532 |
| 128 | neutrophil mediated immunity (GO:0002446) | 2.85591800 |
| 129 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.85235754 |
| 130 | positive regulation of dendritic spine development (GO:0060999) | 2.85186087 |
| 131 | detection of external biotic stimulus (GO:0098581) | 2.84404438 |
| 132 | cell migration in hindbrain (GO:0021535) | 2.83627302 |
| 133 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.82813098 |
| 134 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.80755594 |
| 135 | myeloid cell activation involved in immune response (GO:0002275) | 2.80724076 |
| 136 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.78453890 |
| 137 | negative regulation of T cell mediated immunity (GO:0002710) | 2.77212050 |
| 138 | defense response to protozoan (GO:0042832) | 2.77114414 |
| 139 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.76357237 |
| 140 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.74839260 |
| 141 | positive regulation of mast cell activation (GO:0033005) | 2.73542148 |
| 142 | detection of bacterium (GO:0016045) | 2.72254818 |
| 143 | regulation of gamma-delta T cell activation (GO:0046643) | 2.70195672 |
| 144 | regulation of T cell tolerance induction (GO:0002664) | 2.68667690 |
| 145 | negative regulation of interleukin-17 production (GO:0032700) | 2.66107074 |
| 146 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.65337227 |
| 147 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.63508295 |
| 148 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.62439143 |
| 149 | type I interferon signaling pathway (GO:0060337) | 2.62339968 |
| 150 | cellular response to type I interferon (GO:0071357) | 2.62339968 |
| 151 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.61858373 |
| 152 | positive regulation of mast cell degranulation (GO:0043306) | 2.61858373 |
| 153 | nerve growth factor signaling pathway (GO:0038180) | 2.61285680 |
| 154 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.60737440 |
| 155 | cellular extravasation (GO:0045123) | 2.59154825 |
| 156 | L-amino acid import (GO:0043092) | 2.59037134 |
| 157 | response to host immune response (GO:0052572) | 2.56863320 |
| 158 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.56863320 |
| 159 | response to type I interferon (GO:0034340) | 2.56043857 |
| 160 | myeloid leukocyte mediated immunity (GO:0002444) | 2.54763926 |
| 161 | detection of biotic stimulus (GO:0009595) | 2.54054984 |
| 162 | regulation of mast cell degranulation (GO:0043304) | 2.53508306 |
| 163 | regulation of mast cell activation (GO:0033003) | 2.53011660 |
| 164 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.52847505 |
| 165 | negative regulation of type 2 immune response (GO:0002829) | 2.49303157 |
| 166 | regulation of tolerance induction (GO:0002643) | 2.49165484 |
| 167 | response to protozoan (GO:0001562) | 2.47863259 |
| 168 | response to muramyl dipeptide (GO:0032495) | 2.46593944 |
| 169 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.45495376 |
| 170 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.45204598 |
| 171 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.44655668 |
| 172 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.40517250 |
| 173 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.40379438 |
| 174 | regulation of interleukin-12 production (GO:0032655) | 2.40254549 |
| 175 | regulation of regulated secretory pathway (GO:1903305) | 2.37827402 |
| 176 | regulation of antigen processing and presentation (GO:0002577) | 2.37701839 |
| 177 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.36819262 |
| 178 | response to nerve growth factor (GO:1990089) | 2.36819262 |
| 179 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.36050564 |
| 180 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.35832711 |
| 181 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.35221706 |
| 182 | regulation of T-helper cell differentiation (GO:0045622) | 2.35217111 |
| 183 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.34070781 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.36699571 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.11657172 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.94378793 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.68208913 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.54296694 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.09991702 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.96415905 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.86602543 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.67601147 |
| 10 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.62751089 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.62034746 |
| 12 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.59016039 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.43344921 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.42717446 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.42717446 |
| 16 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.39891762 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.39260087 |
| 18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.39105560 |
| 19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.37593662 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.35732359 |
| 21 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.31186290 |
| 22 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.29249963 |
| 23 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.26074276 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.23106574 |
| 25 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.20658844 |
| 26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.12322875 |
| 27 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.08914442 |
| 28 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.08053149 |
| 29 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.07150870 |
| 30 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.06996773 |
| 31 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.06518115 |
| 32 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.03117088 |
| 33 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.02951270 |
| 34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.02736068 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.02707105 |
| 36 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.00303372 |
| 37 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.98961160 |
| 38 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.96531534 |
| 39 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.96388987 |
| 40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.95729200 |
| 41 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.90055763 |
| 42 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.89944708 |
| 43 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.86375137 |
| 44 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.84492462 |
| 45 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.82459814 |
| 46 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.80964012 |
| 47 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.77898100 |
| 48 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.75449294 |
| 49 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.73581804 |
| 50 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.73018593 |
| 51 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.71032963 |
| 52 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.69976484 |
| 53 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.68507992 |
| 54 | P300_19829295_ChIP-Seq_ESCs_Human | 1.66439628 |
| 55 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.63722492 |
| 56 | SPI1_23127762_ChIP-Seq_K562_Human | 1.61356000 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.59762338 |
| 58 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.52864843 |
| 59 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.48929451 |
| 60 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.45866460 |
| 61 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.45149198 |
| 62 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.43537443 |
| 63 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.43533585 |
| 64 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.43329611 |
| 65 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.43079583 |
| 66 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.39737701 |
| 67 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.38039474 |
| 68 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.37289330 |
| 69 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34960726 |
| 70 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.34937689 |
| 71 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.33322183 |
| 72 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.31600777 |
| 73 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.30144252 |
| 74 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.29335075 |
| 75 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29309850 |
| 76 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.26726661 |
| 77 | STAT3_23295773_ChIP-Seq_U87_Human | 1.26083984 |
| 78 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.24186551 |
| 79 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.23863540 |
| 80 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.23193906 |
| 81 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23136269 |
| 82 | FUS_26573619_Chip-Seq_HEK293_Human | 1.22728102 |
| 83 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.21336820 |
| 84 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.20976724 |
| 85 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.20528853 |
| 86 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.20100036 |
| 87 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19960511 |
| 88 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.19563679 |
| 89 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.19454379 |
| 90 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.18505339 |
| 91 | * AR_19668381_ChIP-Seq_PC3_Human | 1.17838725 |
| 92 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17265955 |
| 93 | TCF4_23295773_ChIP-Seq_U87_Human | 1.16754105 |
| 94 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.15829612 |
| 95 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.15156251 |
| 96 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.14990298 |
| 97 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.14087315 |
| 98 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.12893747 |
| 99 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12019444 |
| 100 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.11137394 |
| 101 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10524155 |
| 102 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09989066 |
| 103 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09915379 |
| 104 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.09409876 |
| 105 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.07873975 |
| 106 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05511257 |
| 107 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05289045 |
| 108 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.05216008 |
| 109 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.04673757 |
| 110 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04470605 |
| 111 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.04448478 |
| 112 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.04299753 |
| 113 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03283350 |
| 114 | * POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.03271978 |
| 115 | * TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03271978 |
| 116 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.03139275 |
| 117 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02709333 |
| 118 | RXR_22108803_ChIP-Seq_LS180_Human | 1.02679827 |
| 119 | TP53_16413492_ChIP-PET_HCT116_Human | 1.02475670 |
| 120 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.02422478 |
| 121 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02281236 |
| 122 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.01880732 |
| 123 | JUN_21703547_ChIP-Seq_K562_Human | 1.01562010 |
| 124 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.01064935 |
| 125 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.00794062 |
| 126 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99635120 |
| 127 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98969191 |
| 128 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.98788372 |
| 129 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.98145396 |
| 130 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98102160 |
| 131 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97292918 |
| 132 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.96002521 |
| 133 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.95989761 |
| 134 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.95647574 |
| 135 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95411622 |
| 136 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.95303140 |
| 137 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93838423 |
| 138 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.93687806 |
| 139 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93310626 |
| 140 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.89499317 |
| 141 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.88283161 |
| 142 | KDM2B_26808549_Chip-Seq_K562_Human | 0.88033771 |
| 143 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.86234451 |
| 144 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.86089908 |
| 145 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.85640012 |
| 146 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.83702913 |
| 147 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.82315763 |
| 148 | MYB_26560356_Chip-Seq_TH2_Human | 0.81123033 |
| 149 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.79738750 |
| 150 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.78973875 |
| 151 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76973420 |
| 152 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.76834495 |
| 153 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.75741025 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.82090743 |
| 2 | MP0003880_abnormal_central_pattern | 5.18579861 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.32391357 |
| 4 | MP0003724_increased_susceptibility_to | 4.09794607 |
| 5 | MP0004270_analgesia | 3.80162967 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.72094237 |
| 7 | MP0009745_abnormal_behavioral_response | 3.55019703 |
| 8 | MP0002064_seizures | 3.13748050 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.02449233 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.96546138 |
| 11 | MP0006082_CNS_inflammation | 2.95769222 |
| 12 | MP0009046_muscle_twitch | 2.93232156 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.84506169 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.74607796 |
| 15 | MP0003436_decreased_susceptibility_to | 2.71073675 |
| 16 | MP0002822_catalepsy | 2.67875342 |
| 17 | MP0009785_altered_susceptibility_to | 2.61958725 |
| 18 | MP0002734_abnormal_mechanical_nocicepti | 2.55446186 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.46565368 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 2.44940613 |
| 21 | MP0001486_abnormal_startle_reflex | 2.43167747 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.41766812 |
| 23 | MP0005671_abnormal_response_to | 2.41564031 |
| 24 | MP0002736_abnormal_nociception_after | 2.39783850 |
| 25 | MP0000778_abnormal_nervous_system | 2.31587801 |
| 26 | MP0001501_abnormal_sleep_pattern | 2.23631876 |
| 27 | MP0002419_abnormal_innate_immunity | 2.23172588 |
| 28 | MP0005000_abnormal_immune_tolerance | 2.21926034 |
| 29 | MP0002272_abnormal_nervous_system | 2.21823394 |
| 30 | MP0001440_abnormal_grooming_behavior | 2.13866605 |
| 31 | MP0005025_abnormal_response_to | 2.04652084 |
| 32 | MP0002733_abnormal_thermal_nociception | 2.02578010 |
| 33 | MP0000569_abnormal_digit_pigmentation | 1.98828870 |
| 34 | MP0001790_abnormal_immune_system | 1.98704916 |
| 35 | MP0005387_immune_system_phenotype | 1.98704916 |
| 36 | MP0001800_abnormal_humoral_immune | 1.98203215 |
| 37 | MP0003329_amyloid_beta_deposits | 1.94554549 |
| 38 | MP0005386_behavior/neurological_phenoty | 1.91162750 |
| 39 | MP0004924_abnormal_behavior | 1.91162750 |
| 40 | MP0001970_abnormal_pain_threshold | 1.89100206 |
| 41 | MP0003787_abnormal_imprinting | 1.88931578 |
| 42 | MP0002067_abnormal_sensory_capabilities | 1.87528744 |
| 43 | MP0002184_abnormal_innervation | 1.87185504 |
| 44 | MP0004811_abnormal_neuron_physiology | 1.86199647 |
| 45 | MP0002723_abnormal_immune_serum | 1.85508409 |
| 46 | MP0003879_abnormal_hair_cell | 1.77701838 |
| 47 | MP0002452_abnormal_antigen_presenting | 1.77073221 |
| 48 | MP0004858_abnormal_nervous_system | 1.76945316 |
| 49 | MP0004510_myositis | 1.76741315 |
| 50 | MP0009764_decreased_sensitivity_to | 1.75992119 |
| 51 | MP0005167_abnormal_blood-brain_barrier | 1.74552286 |
| 52 | MP0002557_abnormal_social/conspecific_i | 1.73870270 |
| 53 | MP0008569_lethality_at_weaning | 1.67227448 |
| 54 | MP0002420_abnormal_adaptive_immunity | 1.61310532 |
| 55 | MP0001819_abnormal_immune_cell | 1.60555027 |
| 56 | MP0000685_abnormal_immune_system | 1.53311594 |
| 57 | MP0003300_gastrointestinal_ulcer | 1.52350204 |
| 58 | MP0002332_abnormal_exercise_endurance | 1.49961146 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.47091626 |
| 60 | MP0002909_abnormal_adrenal_gland | 1.47065473 |
| 61 | MP0004885_abnormal_endolymph | 1.42082840 |
| 62 | MP0009278_abnormal_bone_marrow | 1.41057698 |
| 63 | MP0000920_abnormal_myelination | 1.41004777 |
| 64 | MP0001984_abnormal_olfaction | 1.39681199 |
| 65 | MP0000955_abnormal_spinal_cord | 1.38654343 |
| 66 | MP0002066_abnormal_motor_capabilities/c | 1.38007976 |
| 67 | MP0005646_abnormal_pituitary_gland | 1.37883000 |
| 68 | MP0001188_hyperpigmentation | 1.35017012 |
| 69 | MP0005166_decreased_susceptibility_to | 1.32060665 |
| 70 | MP0002882_abnormal_neuron_morphology | 1.31141218 |
| 71 | MP0001348_abnormal_lacrimal_gland | 1.28992757 |
| 72 | MP0006276_abnormal_autonomic_nervous | 1.27885706 |
| 73 | MP0000604_amyloidosis | 1.27089712 |
| 74 | MP0008260_abnormal_autophagy | 1.26703447 |
| 75 | MP0003633_abnormal_nervous_system | 1.25670883 |
| 76 | MP0001845_abnormal_inflammatory_respons | 1.24579631 |
| 77 | MP0005058_abnormal_lysosome_morphology | 1.17832678 |
| 78 | MP0004947_skin_inflammation | 1.17428573 |
| 79 | MP0000343_altered_response_to | 1.16636099 |
| 80 | MP0002405_respiratory_system_inflammati | 1.14956861 |
| 81 | MP0005397_hematopoietic_system_phenotyp | 1.13245723 |
| 82 | MP0001545_abnormal_hematopoietic_system | 1.13245723 |
| 83 | MP0004883_abnormal_blood_vessel | 1.13140022 |
| 84 | MP0002876_abnormal_thyroid_physiology | 1.10193968 |
| 85 | MP0010155_abnormal_intestine_physiology | 1.09688836 |
| 86 | MP0002152_abnormal_brain_morphology | 1.09645339 |
| 87 | MP0000716_abnormal_immune_system | 1.09136228 |
| 88 | MP0003631_nervous_system_phenotype | 1.08723269 |
| 89 | MP0001905_abnormal_dopamine_level | 1.07972760 |
| 90 | MP0008004_abnormal_stomach_pH | 1.06552725 |
| 91 | MP0000465_gastrointestinal_hemorrhage | 1.06197659 |
| 92 | MP0001502_abnormal_circadian_rhythm | 1.03869345 |
| 93 | MP0008469_abnormal_protein_level | 1.02695134 |
| 94 | MP0003303_peritoneal_inflammation | 1.00235397 |
| 95 | MP0001529_abnormal_vocalization | 0.96959314 |
| 96 | MP0005464_abnormal_platelet_physiology | 0.96440788 |
| 97 | MP0008874_decreased_physiological_sensi | 0.96389576 |
| 98 | MP0005645_abnormal_hypothalamus_physiol | 0.96193555 |
| 99 | MP0003828_pulmonary_edema | 0.94469819 |
| 100 | MP0008872_abnormal_physiological_respon | 0.92083602 |
| 101 | MP0002398_abnormal_bone_marrow | 0.91371328 |
| 102 | MP0002998_abnormal_bone_remodeling | 0.90906333 |
| 103 | MP0003448_altered_tumor_morphology | 0.88720331 |
| 104 | MP0003191_abnormal_cellular_cholesterol | 0.87706418 |
| 105 | MP0005164_abnormal_response_to | 0.86461902 |
| 106 | MP0002069_abnormal_eating/drinking_beha | 0.86311822 |
| 107 | MP0003183_abnormal_peptide_metabolism | 0.83539321 |
| 108 | MP0003656_abnormal_erythrocyte_physiolo | 0.83464052 |
| 109 | MP0002277_abnormal_respiratory_mucosa | 0.83303458 |
| 110 | MP0005499_abnormal_olfactory_system | 0.83263394 |
| 111 | MP0005394_taste/olfaction_phenotype | 0.83263394 |
| 112 | MP0004142_abnormal_muscle_tone | 0.79524391 |
| 113 | MP0003075_altered_response_to | 0.78905787 |
| 114 | MP0001853_heart_inflammation | 0.78585649 |
| 115 | MP0005451_abnormal_body_composition | 0.78004472 |
| 116 | MP0005535_abnormal_body_temperature | 0.77508752 |
| 117 | MP0002837_dystrophic_cardiac_calcinosis | 0.77463731 |
| 118 | MP0001177_atelectasis | 0.76663972 |
| 119 | MP0004742_abnormal_vestibular_system | 0.74909174 |
| 120 | MP0004085_abnormal_heartbeat | 0.73309192 |
| 121 | MP0003634_abnormal_glial_cell | 0.72224559 |
| 122 | MP0003632_abnormal_nervous_system | 0.71498294 |
| 123 | MP0001963_abnormal_hearing_physiology | 0.71382245 |
| 124 | MP0003172_abnormal_lysosome_physiology | 0.69538806 |
| 125 | MP0001986_abnormal_taste_sensitivity | 0.69452011 |
| 126 | MP0000689_abnormal_spleen_morphology | 0.69254509 |
| 127 | MP0002429_abnormal_blood_cell | 0.67850566 |
| 128 | MP0010386_abnormal_urinary_bladder | 0.67160150 |
| 129 | MP0003045_fibrosis | 0.66802280 |
| 130 | MP0000631_abnormal_neuroendocrine_gland | 0.66629717 |
| 131 | MP0002229_neurodegeneration | 0.65761590 |
| 132 | MP0004484_altered_response_of | 0.65035173 |
| 133 | MP0002254_reproductive_system_inflammat | 0.63950726 |
| 134 | MP0000015_abnormal_ear_pigmentation | 0.62314898 |
| 135 | MP0003122_maternal_imprinting | 0.58587011 |
| 136 | MP0004130_abnormal_muscle_cell | 0.58328399 |
| 137 | MP0002163_abnormal_gland_morphology | 0.57643434 |
| 138 | MP0002090_abnormal_vision | 0.57337645 |
| 139 | MP0005310_abnormal_salivary_gland | 0.56231529 |
| 140 | MP0000751_myopathy | 0.55578208 |
| 141 | MP0003861_abnormal_nervous_system | 0.54231794 |
| 142 | MP0005187_abnormal_penis_morphology | 0.53955949 |
| 143 | MP0002752_abnormal_somatic_nervous | 0.52721151 |
| 144 | MP0005409_darkened_coat_color | 0.49701223 |
| 145 | MP0004215_abnormal_myocardial_fiber | 0.49007859 |
| 146 | MP0002082_postnatal_lethality | 0.48757698 |
| 147 | MP0010770_preweaning_lethality | 0.48757698 |
| 148 | MP0010769_abnormal_survival | 0.48633395 |
| 149 | MP0006292_abnormal_olfactory_placode | 0.47562235 |
| 150 | MP0003690_abnormal_glial_cell | 0.47209110 |
| 151 | MP0003956_abnormal_body_size | 0.45670046 |
| 152 | MP0001943_abnormal_respiration | 0.45593381 |
| 153 | MP0000681_abnormal_thyroid_gland | 0.44768574 |
| 154 | MP0010768_mortality/aging | 0.44630483 |
| 155 | MP0010234_abnormal_vibrissa_follicle | 0.43657242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.38195954 |
| 2 | Myokymia (HP:0002411) | 5.84764151 |
| 3 | Epileptic encephalopathy (HP:0200134) | 5.63182161 |
| 4 | Focal seizures (HP:0007359) | 5.36430691 |
| 5 | Hyperventilation (HP:0002883) | 5.04134875 |
| 6 | Visual hallucinations (HP:0002367) | 4.76959074 |
| 7 | Optic neuritis (HP:0100653) | 4.75006358 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 4.75006358 |
| 9 | Orchitis (HP:0100796) | 4.56916703 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 4.47870206 |
| 11 | Atonic seizures (HP:0010819) | 4.35172773 |
| 12 | Febrile seizures (HP:0002373) | 4.34565069 |
| 13 | Myositis (HP:0100614) | 4.29945120 |
| 14 | Broad-based gait (HP:0002136) | 4.29941228 |
| 15 | Eczematoid dermatitis (HP:0000976) | 4.15990209 |
| 16 | Recurrent abscess formation (HP:0002722) | 4.15706597 |
| 17 | Abnormality of macrophages (HP:0004311) | 4.15407089 |
| 18 | Stomatitis (HP:0010280) | 4.11909765 |
| 19 | Supranuclear gaze palsy (HP:0000605) | 4.00488716 |
| 20 | Poor eye contact (HP:0000817) | 3.98005805 |
| 21 | Absence seizures (HP:0002121) | 3.90387566 |
| 22 | Mutism (HP:0002300) | 3.78387500 |
| 23 | Progressive cerebellar ataxia (HP:0002073) | 3.74029660 |
| 24 | Excessive salivation (HP:0003781) | 3.64931995 |
| 25 | Drooling (HP:0002307) | 3.64931995 |
| 26 | Dialeptic seizures (HP:0011146) | 3.58639265 |
| 27 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.57960261 |
| 28 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.57960261 |
| 29 | Abnormality of glycolipid metabolism (HP:0010969) | 3.57960261 |
| 30 | Impaired social interactions (HP:0000735) | 3.50281429 |
| 31 | Abnormal social behavior (HP:0012433) | 3.50281429 |
| 32 | Generalized tonic-clonic seizures (HP:0002069) | 3.43113245 |
| 33 | Keratoconjunctivitis sicca (HP:0001097) | 3.36409116 |
| 34 | Papilledema (HP:0001085) | 3.32411939 |
| 35 | Amyotrophic lateral sclerosis (HP:0007354) | 3.31015860 |
| 36 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.30026604 |
| 37 | Progressive inability to walk (HP:0002505) | 3.28509689 |
| 38 | Mediastinal lymphadenopathy (HP:0100721) | 3.26141445 |
| 39 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.24126822 |
| 40 | Abnormality of binocular vision (HP:0011514) | 3.19294890 |
| 41 | Diplopia (HP:0000651) | 3.19294890 |
| 42 | Cerebral inclusion bodies (HP:0100314) | 3.17558791 |
| 43 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.13702728 |
| 44 | Inappropriate behavior (HP:0000719) | 3.10753697 |
| 45 | Keratoconjunctivitis (HP:0001096) | 3.09562769 |
| 46 | Neurofibrillary tangles (HP:0002185) | 3.05339009 |
| 47 | Gaze-evoked nystagmus (HP:0000640) | 3.02939570 |
| 48 | Inability to walk (HP:0002540) | 2.96369376 |
| 49 | Amblyopia (HP:0000646) | 2.96021936 |
| 50 | Truncal ataxia (HP:0002078) | 2.92953828 |
| 51 | Gastrointestinal infarctions (HP:0005244) | 2.92225349 |
| 52 | Epileptiform EEG discharges (HP:0011182) | 2.91629063 |
| 53 | Ankle clonus (HP:0011448) | 2.91029590 |
| 54 | Abnormal eating behavior (HP:0100738) | 2.86127930 |
| 55 | Depression (HP:0000716) | 2.84161100 |
| 56 | Polyphagia (HP:0002591) | 2.81660725 |
| 57 | Stereotypic behavior (HP:0000733) | 2.79649236 |
| 58 | Absent speech (HP:0001344) | 2.79395048 |
| 59 | Action tremor (HP:0002345) | 2.76742928 |
| 60 | Amyloidosis (HP:0011034) | 2.76623711 |
| 61 | Abnormality of the corticospinal tract (HP:0002492) | 2.76560186 |
| 62 | Hemoptysis (HP:0002105) | 2.76071918 |
| 63 | Recurrent fungal infections (HP:0002841) | 2.74963397 |
| 64 | Protruding tongue (HP:0010808) | 2.73882531 |
| 65 | Genetic anticipation (HP:0003743) | 2.73506725 |
| 66 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.73397449 |
| 67 | Akinesia (HP:0002304) | 2.73088811 |
| 68 | Vasculitis (HP:0002633) | 2.72581232 |
| 69 | Memory impairment (HP:0002354) | 2.70954896 |
| 70 | EEG with generalized epileptiform discharges (HP:0011198) | 2.70684418 |
| 71 | Urinary urgency (HP:0000012) | 2.69904674 |
| 72 | Postural instability (HP:0002172) | 2.69334974 |
| 73 | Recurrent skin infections (HP:0001581) | 2.64249394 |
| 74 | T lymphocytopenia (HP:0005403) | 2.64136250 |
| 75 | Meningitis (HP:0001287) | 2.62879638 |
| 76 | Hypsarrhythmia (HP:0002521) | 2.60627271 |
| 77 | Obstructive lung disease (HP:0006536) | 2.60601102 |
| 78 | Chronic obstructive pulmonary disease (HP:0006510) | 2.60601102 |
| 79 | Obstructive sleep apnea (HP:0002870) | 2.57833951 |
| 80 | Dysdiadochokinesis (HP:0002075) | 2.57250399 |
| 81 | Impaired smooth pursuit (HP:0007772) | 2.55626426 |
| 82 | Abnormality of T cell number (HP:0011839) | 2.55246743 |
| 83 | Limb dystonia (HP:0002451) | 2.54639123 |
| 84 | Pulmonary infiltrates (HP:0002113) | 2.53585833 |
| 85 | Encephalitis (HP:0002383) | 2.52554998 |
| 86 | Anxiety (HP:0000739) | 2.52241629 |
| 87 | Hemiparesis (HP:0001269) | 2.51916105 |
| 88 | Torticollis (HP:0000473) | 2.51212597 |
| 89 | Dysmetria (HP:0001310) | 2.48806693 |
| 90 | Increased cerebral lipofuscin (HP:0011813) | 2.48694381 |
| 91 | Bradykinesia (HP:0002067) | 2.47264388 |
| 92 | Insidious onset (HP:0003587) | 2.46412687 |
| 93 | Termporal pattern (HP:0011008) | 2.46412687 |
| 94 | Abnormality of salivation (HP:0100755) | 2.46306912 |
| 95 | Loss of speech (HP:0002371) | 2.45543948 |
| 96 | Episodic fever (HP:0001954) | 2.43723688 |
| 97 | Fetal akinesia sequence (HP:0001989) | 2.43620833 |
| 98 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.42202708 |
| 99 | Vertigo (HP:0002321) | 2.41468862 |
| 100 | Abnormality of the lower motor neuron (HP:0002366) | 2.37531822 |
| 101 | Spontaneous hematomas (HP:0007420) | 2.37228616 |
| 102 | Gangrene (HP:0100758) | 2.37208168 |
| 103 | Spastic gait (HP:0002064) | 2.36517541 |
| 104 | Blue irides (HP:0000635) | 2.35380270 |
| 105 | Chest pain (HP:0100749) | 2.34010785 |
| 106 | Leukocytosis (HP:0001974) | 2.32389277 |
| 107 | Gingivitis (HP:0000230) | 2.29971399 |
| 108 | Dysmetric saccades (HP:0000641) | 2.28877302 |
| 109 | Autoimmune thrombocytopenia (HP:0001973) | 2.28764229 |
| 110 | Apathy (HP:0000741) | 2.27878765 |
| 111 | Urticaria (HP:0001025) | 2.26787095 |
| 112 | Focal dystonia (HP:0004373) | 2.25752061 |
| 113 | Dysostosis multiplex (HP:0000943) | 2.22193776 |
| 114 | Lower limb muscle weakness (HP:0007340) | 2.18800209 |
| 115 | Pulmonary embolism (HP:0002204) | 2.17479830 |
| 116 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.15043576 |
| 117 | Impaired vibratory sensation (HP:0002495) | 2.13651188 |
| 118 | Lower limb amyotrophy (HP:0007210) | 2.13409305 |
| 119 | Agnosia (HP:0010524) | 2.10628256 |
| 120 | Delusions (HP:0000746) | 2.09623342 |
| 121 | Arterial thrombosis (HP:0004420) | 2.08642527 |
| 122 | Increased IgM level (HP:0003496) | 2.06263280 |
| 123 | Megalencephaly (HP:0001355) | 2.05954598 |
| 124 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.05903266 |
| 125 | Recurrent cutaneous fungal infections (HP:0011370) | 2.05903266 |
| 126 | Generalized hypopigmentation of hair (HP:0011358) | 2.02012308 |
| 127 | Craniofacial dystonia (HP:0012179) | 2.01819602 |
| 128 | Pheochromocytoma (HP:0002666) | 1.99818025 |
| 129 | Intellectual disability, severe (HP:0010864) | 1.99155187 |
| 130 | Diminished motivation (HP:0000745) | 1.98818137 |
| 131 | Generalized myoclonic seizures (HP:0002123) | 1.97337986 |
| 132 | Gait imbalance (HP:0002141) | 1.95838860 |
| 133 | Hepatoblastoma (HP:0002884) | 1.94521022 |
| 134 | Hemiplegia (HP:0002301) | 1.93560145 |
| 135 | Abnormality of the pleura (HP:0002103) | 1.92612271 |
| 136 | Widely spaced teeth (HP:0000687) | 1.91435925 |
| 137 | Slow saccadic eye movements (HP:0000514) | 1.91347030 |
| 138 | Recurrent viral infections (HP:0004429) | 1.91267299 |
| 139 | Sporadic (HP:0003745) | 1.90805848 |
| 140 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.90170531 |
| 141 | Incomplete penetrance (HP:0003829) | 1.89857376 |
| 142 | Rapidly progressive (HP:0003678) | 1.89196890 |
| 143 | Anorexia (HP:0002039) | 1.87995315 |
| 144 | Scanning speech (HP:0002168) | 1.86926363 |
| 145 | Intention tremor (HP:0002080) | 1.86584019 |
| 146 | Sleep apnea (HP:0010535) | 1.86566876 |
| 147 | Progressive microcephaly (HP:0000253) | 1.86164590 |
| 148 | Agitation (HP:0000713) | 1.85753194 |
| 149 | Abnormal hair whorl (HP:0010721) | 1.85574361 |
| 150 | Eosinophilia (HP:0001880) | 1.85044195 |
| 151 | Aqueductal stenosis (HP:0002410) | 1.84588351 |
| 152 | Neuronal loss in central nervous system (HP:0002529) | 1.83922543 |
| 153 | Increased IgE level (HP:0003212) | 1.83008607 |
| 154 | Gait ataxia (HP:0002066) | 1.82398043 |
| 155 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.82131718 |
| 156 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.82131718 |
| 157 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.82131718 |
| 158 | Palpebral edema (HP:0100540) | 1.82033717 |
| 159 | Intellectual disability, profound (HP:0002187) | 1.80867456 |
| 160 | Pachygyria (HP:0001302) | 1.80613981 |
| 161 | Disinhibition (HP:0000734) | 1.80106692 |
| 162 | Fair hair (HP:0002286) | 1.79980440 |
| 163 | Neuroendocrine neoplasm (HP:0100634) | 1.78041081 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 5.37697834 |
| 2 | EPHA4 | 4.31423295 |
| 3 | NTRK3 | 3.87937726 |
| 4 | MAP3K9 | 3.54501467 |
| 5 | CASK | 3.41491520 |
| 6 | MAP3K4 | 3.00267726 |
| 7 | MAP2K7 | 2.91364762 |
| 8 | DAPK2 | 2.75944875 |
| 9 | MINK1 | 2.47015602 |
| 10 | RIPK4 | 2.46937563 |
| 11 | MAP3K12 | 2.38821899 |
| 12 | BLK | 2.36062981 |
| 13 | DAPK1 | 2.03592640 |
| 14 | NTRK2 | 2.00499824 |
| 15 | PLK2 | 1.83980402 |
| 16 | IRAK4 | 1.81230188 |
| 17 | CSK | 1.77987177 |
| 18 | MAP2K4 | 1.76501911 |
| 19 | GRK7 | 1.74503195 |
| 20 | TYK2 | 1.73403288 |
| 21 | KSR1 | 1.70991126 |
| 22 | PAK6 | 1.69357096 |
| 23 | MAPK13 | 1.60077168 |
| 24 | KSR2 | 1.59582985 |
| 25 | MAP4K1 | 1.58162606 |
| 26 | CDK19 | 1.57338975 |
| 27 | CAMKK1 | 1.57081463 |
| 28 | SIK2 | 1.51225731 |
| 29 | TXK | 1.50465426 |
| 30 | CDK5 | 1.50190412 |
| 31 | MATK | 1.43479829 |
| 32 | MAP3K13 | 1.42321801 |
| 33 | MAP3K11 | 1.41536435 |
| 34 | PRPF4B | 1.29684258 |
| 35 | GRK5 | 1.26598047 |
| 36 | CCNB1 | 1.25732150 |
| 37 | IKBKE | 1.24156704 |
| 38 | JAK2 | 1.23032803 |
| 39 | PHKG2 | 1.20755154 |
| 40 | PHKG1 | 1.20755154 |
| 41 | BMPR2 | 1.20045103 |
| 42 | JAK1 | 1.17755140 |
| 43 | NTRK1 | 1.16868455 |
| 44 | IRAK3 | 1.16329043 |
| 45 | TNK2 | 1.09632696 |
| 46 | TNIK | 1.08913622 |
| 47 | TBK1 | 1.08209941 |
| 48 | JAK3 | 1.04816973 |
| 49 | FES | 1.03538536 |
| 50 | PRKCG | 1.03301737 |
| 51 | CAMKK2 | 1.00755833 |
| 52 | LATS2 | 0.99808764 |
| 53 | LYN | 0.97657510 |
| 54 | ZAP70 | 0.97648631 |
| 55 | IRAK2 | 0.95998279 |
| 56 | HCK | 0.95711433 |
| 57 | MAP2K3 | 0.93961460 |
| 58 | PKN1 | 0.93537012 |
| 59 | EPHA3 | 0.93004069 |
| 60 | MAP3K5 | 0.91992395 |
| 61 | CAMK2A | 0.91459345 |
| 62 | RIPK1 | 0.90739457 |
| 63 | TAOK2 | 0.90605312 |
| 64 | MOS | 0.90389693 |
| 65 | PRKD3 | 0.90327535 |
| 66 | MAP3K3 | 0.89746439 |
| 67 | STK11 | 0.87101897 |
| 68 | DYRK2 | 0.86758418 |
| 69 | RET | 0.85744494 |
| 70 | ARAF | 0.85581330 |
| 71 | MAP3K2 | 0.84977855 |
| 72 | PTK2B | 0.84519925 |
| 73 | TAOK3 | 0.80594071 |
| 74 | SGK2 | 0.80001773 |
| 75 | SGK1 | 0.79972126 |
| 76 | EPHB1 | 0.78821953 |
| 77 | FGR | 0.78133476 |
| 78 | CDK18 | 0.77578683 |
| 79 | DYRK1A | 0.76953898 |
| 80 | RAF1 | 0.73329143 |
| 81 | CDK15 | 0.73115208 |
| 82 | IKBKB | 0.71217927 |
| 83 | CDK14 | 0.71180525 |
| 84 | SGK494 | 0.68615310 |
| 85 | SGK223 | 0.68615310 |
| 86 | SIK3 | 0.68578518 |
| 87 | MAP3K6 | 0.68419534 |
| 88 | PRKCZ | 0.68213146 |
| 89 | IRAK1 | 0.68203097 |
| 90 | ERBB3 | 0.67931433 |
| 91 | CSNK1G2 | 0.66179828 |
| 92 | LCK | 0.65592193 |
| 93 | PRKCE | 0.65363498 |
| 94 | SGK3 | 0.64208151 |
| 95 | CAMK2B | 0.63685738 |
| 96 | BTK | 0.63198425 |
| 97 | MAPK12 | 0.63068543 |
| 98 | CSF1R | 0.63018243 |
| 99 | MARK2 | 0.61862374 |
| 100 | TYRO3 | 0.61274319 |
| 101 | CDK11A | 0.60886744 |
| 102 | TGFBR2 | 0.59305774 |
| 103 | TAOK1 | 0.58706545 |
| 104 | DYRK1B | 0.55986330 |
| 105 | PNCK | 0.55858358 |
| 106 | PINK1 | 0.54821189 |
| 107 | CAMK1 | 0.54587327 |
| 108 | YES1 | 0.54244768 |
| 109 | OXSR1 | 0.52189478 |
| 110 | FYN | 0.52150725 |
| 111 | STK38 | 0.51393683 |
| 112 | BCR | 0.50765586 |
| 113 | AKT3 | 0.49781788 |
| 114 | PDK1 | 0.49599493 |
| 115 | SCYL2 | 0.49577121 |
| 116 | PRKCQ | 0.48297355 |
| 117 | PRKCH | 0.47386987 |
| 118 | INSRR | 0.47223355 |
| 119 | DAPK3 | 0.47088604 |
| 120 | UHMK1 | 0.46847855 |
| 121 | MAPK4 | 0.46832823 |
| 122 | PAK3 | 0.46697280 |
| 123 | MAPK7 | 0.46034815 |
| 124 | RPS6KA2 | 0.45905709 |
| 125 | MAP3K14 | 0.45901853 |
| 126 | MAP2K6 | 0.42608377 |
| 127 | SYK | 0.41597352 |
| 128 | PDPK1 | 0.38140566 |
| 129 | RPS6KA3 | 0.38065622 |
| 130 | ALK | 0.36575004 |
| 131 | GRK6 | 0.31526303 |
| 132 | CAMK4 | 0.28999005 |
| 133 | PRKCB | 0.28949661 |
| 134 | DMPK | 0.26375830 |
| 135 | MAPK10 | 0.25851386 |
| 136 | MAP2K1 | 0.25507115 |
| 137 | STK24 | 0.23334611 |
| 138 | TSSK6 | 0.22757518 |
| 139 | MAP3K7 | 0.21824394 |
| 140 | ADRBK1 | 0.21586373 |
| 141 | MAP3K1 | 0.20272471 |
| 142 | MAPK8 | 0.19935905 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.46201952 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.02052780 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.66009183 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.60683401 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.58934773 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.58492803 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.53415798 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.43113940 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.41285413 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.22944311 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.18641149 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.10009364 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.08300246 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 2.02961193 |
| 15 | Salivary secretion_Homo sapiens_hsa04970 | 1.96842084 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.93111474 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.93111239 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.82959550 |
| 19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.82216410 |
| 20 | Renin secretion_Homo sapiens_hsa04924 | 1.80987984 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.76708235 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.72310367 |
| 23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.65348723 |
| 24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.63816279 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.63313454 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.62148437 |
| 27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.60677879 |
| 28 | Asthma_Homo sapiens_hsa05310 | 1.60198755 |
| 29 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.59080806 |
| 30 | Insulin secretion_Homo sapiens_hsa04911 | 1.54400696 |
| 31 | Taste transduction_Homo sapiens_hsa04742 | 1.53804671 |
| 32 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.49275584 |
| 33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.47511274 |
| 34 | Malaria_Homo sapiens_hsa05144 | 1.42271978 |
| 35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.41907272 |
| 36 | Axon guidance_Homo sapiens_hsa04360 | 1.41051381 |
| 37 | Cocaine addiction_Homo sapiens_hsa05030 | 1.36823170 |
| 38 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.34235513 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.33930073 |
| 40 | Pertussis_Homo sapiens_hsa05133 | 1.32902009 |
| 41 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.31756879 |
| 42 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.30537689 |
| 43 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.28561756 |
| 44 | Gap junction_Homo sapiens_hsa04540 | 1.26457877 |
| 45 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.25427808 |
| 46 | Glioma_Homo sapiens_hsa05214 | 1.20941854 |
| 47 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.20732107 |
| 48 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.20075716 |
| 49 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.19869794 |
| 50 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.19312003 |
| 51 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.17203884 |
| 52 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.14969181 |
| 53 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.14063093 |
| 54 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.13537324 |
| 55 | Influenza A_Homo sapiens_hsa05164 | 1.12729806 |
| 56 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.08854425 |
| 57 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.06058179 |
| 58 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.05193367 |
| 59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.00580633 |
| 60 | Viral myocarditis_Homo sapiens_hsa05416 | 1.00368828 |
| 61 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.99086135 |
| 62 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.97398387 |
| 63 | Measles_Homo sapiens_hsa05162 | 0.97182527 |
| 64 | Lysosome_Homo sapiens_hsa04142 | 0.96456626 |
| 65 | Melanogenesis_Homo sapiens_hsa04916 | 0.93112776 |
| 66 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.92913187 |
| 67 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.92318911 |
| 68 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.89922469 |
| 69 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88639457 |
| 70 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.85980895 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.85898331 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85100908 |
| 73 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.82474608 |
| 74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81844672 |
| 75 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.79843879 |
| 76 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78088365 |
| 77 | Prion diseases_Homo sapiens_hsa05020 | 0.77465459 |
| 78 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76765001 |
| 79 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.76746739 |
| 80 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76364825 |
| 81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76038894 |
| 82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.74475822 |
| 83 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.74210192 |
| 84 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.73891048 |
| 85 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.72143498 |
| 86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71495279 |
| 87 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.71309455 |
| 88 | Shigellosis_Homo sapiens_hsa05131 | 0.69728521 |
| 89 | Hepatitis B_Homo sapiens_hsa05161 | 0.69419687 |
| 90 | Hepatitis C_Homo sapiens_hsa05160 | 0.69048763 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68002927 |
| 92 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.67639659 |
| 93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.66167088 |
| 94 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.65617946 |
| 95 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.64884367 |
| 96 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.63101947 |
| 97 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.62761321 |
| 98 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.62493559 |
| 99 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.61988467 |
| 100 | Colorectal cancer_Homo sapiens_hsa05210 | 0.61766361 |
| 101 | Phototransduction_Homo sapiens_hsa04744 | 0.61711594 |
| 102 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.61252085 |
| 103 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.60624067 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60372057 |
| 105 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.60305146 |
| 106 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.59070154 |
| 107 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58993906 |
| 108 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57555446 |
| 109 | Platelet activation_Homo sapiens_hsa04611 | 0.57427478 |
| 110 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56194597 |
| 111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55981594 |
| 112 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.54861481 |
| 113 | Amoebiasis_Homo sapiens_hsa05146 | 0.53690333 |
| 114 | Tuberculosis_Homo sapiens_hsa05152 | 0.53381036 |
| 115 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.52910633 |
| 116 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.52214687 |
| 117 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51885869 |
| 118 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.50808842 |
| 119 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.50801302 |
| 120 | Endocytosis_Homo sapiens_hsa04144 | 0.48524669 |
| 121 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47405140 |
| 122 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.46243710 |
| 123 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.46236311 |
| 124 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45715156 |
| 125 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.44636054 |
| 126 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44058436 |
| 127 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43535306 |
| 128 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.42411115 |
| 129 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.42340049 |
| 130 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.41691116 |
| 131 | Salmonella infection_Homo sapiens_hsa05132 | 0.40347713 |
| 132 | Alcoholism_Homo sapiens_hsa05034 | 0.40303038 |
| 133 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39843705 |
| 134 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.39755443 |
| 135 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.39645821 |
| 136 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38674186 |
| 137 | Phagosome_Homo sapiens_hsa04145 | 0.38629476 |

